Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

Growth Factor Research

Sermorelin

In Stock

Price range: $104.00 through $190.00

Sermorelin, also known as GRF 1-29 or GHRH 1-29, is a synthetic 29-amino-acid peptide corresponding to the shortest fully active fragment of growth hormone-releasing hormone. It is supplied for laboratory research into GHRH receptor signalling, somatotroph activity, GH-secretion models, and comparative GHRH-analog pharmacology.

99%+ Purity
Lab Tested
Fast Shipping
COA Available
SKU: N/A Category:

Description

/* Reset & Base */
* {
box-sizing: border-box;
margin: 0;
padding: 0;
}
body {
font-family: ‘Inter’, -apple-system, BlinkMacSystemFont, ‘Segoe UI’, Roboto, Helvetica, Arial, sans-serif;
background: #fff;
color: #1e1e1e;
line-height: 1.6;
}
/* Utilities */
.sm-container {
max-width: 1300px;
margin: 0 auto;
padding: 20px 32px 60px;
width: 100%;
}
.sm-flex {
display: flex;
flex-wrap: wrap;
}
.sm-grid-2 {
display: grid;
grid-template-columns: 1fr 1fr;
gap: 40px;
}
.sm-grid-3 {
display: grid;
grid-template-columns: repeat(3, 1fr);
gap: 24px;
}
.sm-grid-4 {
display: grid;
grid-template-columns: repeat(4, 1fr);
gap: 20px;
}
/* Tabs */
.sm-tab-input {
display: none;
}
.sm-panel {
display: none;
}
#sm-tab-product:checked~.sm-tab-nav label[for=”sm-tab-product”],
#sm-tab-disclaimer:checked~.sm-tab-nav label[for=”sm-tab-disclaimer”] {
background: #F27444;
color: #fff;
border-color: #F27444;
box-shadow: 0 8px 20px rgba(242, 116, 68, 0.25);
}
#sm-tab-product:checked~.sm-product-panel {
display: block;
}
#sm-tab-disclaimer:checked~.sm-disclaimer-panel {
display: block;
}
/* FAQ */
.sm-faq summary::-webkit-details-marker {
display: none;
}
.sm-faq[open] .sm-plus {
transform: rotate(45deg);
}
/* Chips */
.sm-chip {
display: inline-block;
padding: 8px 16px;
border-radius: 999px;
background: #fff4ef;
border: 1px solid #ffd9cb;
color: #F27444;
font-weight: 600;
font-size: 0.9rem;
margin: 4px 6px 4px 0;
letter-spacing: 0.02em;
}
/* Cards & Hover */
.sm-card {
background: #fff;
border: 1px solid #f0e8e4;
border-radius: 28px;
padding: 28px;
transition: all 0.2s ease-in-out;
}
.sm-card:hover {
transform: translateY(-4px);
box-shadow: 0 20px 40px -12px rgba(0, 0, 0, 0.08);
border-color: #F27444;
}
.sm-card-glow {
background: linear-gradient(135deg, #fff 0%, #fff8f5 100%);
border: 1px solid #ffe1d6;
}
/* Specs Zebra */
.sm-spec-grid {
display: grid;
grid-template-columns: 1fr 1fr;
}
.sm-spec-item {
padding: 16px 24px;
border-bottom: 1px solid #f0e8e4;
background: #fff;
}
.sm-spec-item:nth-child(odd) {
background: #fcfaf9;
}
/* Responsive */
@media(max-width:768px) {
.sm-container {
padding: 20px 16px 40px;
}
.sm-grid-2,
.sm-grid-3,
.sm-grid-4 {
grid-template-columns: 1fr !important;
gap: 20px;
}
.sm-spec-grid {
grid-template-columns: 1fr;
}
.sm-tab {
width: 100% !important;
text-align: center !important;
}
.sm-hero-title {
font-size: 32px !important;
}
h2 {
font-size: 24px !important;
}
}
/* Misc */
.sm-tab {
font-size: 1rem;
padding: 12px 32px;
border-radius: 999px;
background: #fff;
border: 1px solid #e0d6d0;
color: #1e1e1e;
cursor: pointer;
font-weight: 600;
transition: all 0.2s;
user-select: none;
}
.sm-tab:hover {
background: #fff4ef;
border-color: #F27444;
}
.sm-hero-bg {
background: radial-gradient(ellipse at 70% 20%, rgba(242, 116, 68, 0.04) 0%, rgba(255, 255, 255, 0) 70%);
}
/* Reference list item hover */
.ref-item {
padding: 16px 20px;
background: #fff;
border-radius: 16px;
border: 1px solid #f0e8e4;
transition: all 0.2s ease-in-out;
}
.ref-item:hover {
border-color: #F27444;
box-shadow: 0 4px 12px rgba(242, 116, 68, 0.08);
}
.ref-item a {
color: #F27444;
font-weight: 700;
text-decoration: none;
}
.ref-item a:hover {
text-decoration: underline;
}

Sermorelin (GRF 1-29) | GHRH-Receptor Research Peptide | SaiyanMed




SaiyanMed Research Grade

Sermorelin (GRF 1-29)

Shortest fully active GHRH fragment · GHRH-receptor agonist · research grade

Research-grade Sermorelin (GRF 1-29 / GHRH 1-29) is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal region of human growth-hormone-releasing hormone. It is supplied for laboratory investigation of GHRH-receptor signalling, somatotroph response, peptide stability, and comparative GHRH-analog pharmacology. Each vial is lyophilized, tested to ≥98% purity by HPLC, identity-confirmed by mass spectrometry, and supported by a batch-specific third-party COA. For research use only — not for human or veterinary use.

≥98% HPLC
MS Confirmed
Third-Party COA
Lyophilized
Global Warehouse Fulfillment

Native GRF Reference Fragment

GHRH(1-29)-NH₂

An unmodified reference peptide for comparing native GRF(1-29) with stabilized analogs such as Mod GRF 1-29 and full-length GHRH analogs.

29 AA
CAS 86168-78-7
GHRHR Agonist
RUO

Research Context

Unmodified GHRH Fragment

Sermorelin is useful as a short-lived baseline compound in studies examining GHRHR activation, rapid peptide clearance, and the effect of sequence substitutions introduced into longer-lasting GHRH analogs.

Native GRF(1-29)
Rapid Clearance
Analog Benchmarking

What is Sermorelin?

Sermorelin (GRF 1-29; GHRH 1-29; historically marketed as Geref) is a synthetic, C-terminally amidated 29-amino-acid peptide corresponding to residues 1–29 of human GHRH. This N-terminal segment retains the principal receptor-activating region of the native 44-amino-acid hormone and functions as an agonist at the growth-hormone-releasing hormone receptor (GHRHR), a class B GPCR.

In experimental systems, GHRHR activation engages Gs-dependent adenylyl-cyclase signalling, increasing cAMP and downstream PKA/CREB activity in responsive cells. Because sermorelin retains the native sequence, it is rapidly inactivated by enzymatic cleavage and other degradation pathways; reported circulating half-life estimates are short and method-dependent, commonly falling within approximately 5–12 minutes.

This makes sermorelin a useful comparator for stabilized derivatives. Mod GRF 1-29 introduces substitutions at positions 2, 8, 15, and 27 to improve resistance to degradation, while tesamorelin uses a different stabilization strategy on full-length GHRH(1-44).

🧪 Research Applications

①

GHRHR Signalling

GHRH-receptor activation and downstream cAMP / PKA / CREB pathway models.

②

Somatotroph Response

Experimental models evaluating receptor-coupled secretory responses in GHRHR-expressing systems.

③

Fragment Activity

Study of the minimal active N-terminal region of full-length human GHRH.

④

Analog Comparison

Side-by-side comparison with Mod GRF 1-29, CJC-1295, tesamorelin, and native GHRH.

⑤

Peptide Degradation

Enzymatic-cleavage, stability, and rapid-clearance studies using an unmodified GRF sequence.

⑥

Dual-Pathway Models

Laboratory studies combining GHRHR agonism with ghrelin-receptor secretagogue pathways.

📊 Quick Specs

Form: Lyophilized powder (white to off-white)
Purity: ≥98% by HPLC
Identity: Molecular mass confirmed by MS
CAS Number: 86168-78-7
Also Known As: GRF(1-29), GHRH(1-29), Geref
Sequence Length: 29 amino acids; C-terminal amide
Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Molecular Formula: C149H246N44O42S
Molecular Weight: ~3357.9 Da
Receptor Target: GHRH receptor (GHRHR, class B GPCR)
Peptide Type: Unmodified human GHRH(1-29) fragment
Reported Half-Life: ~5–12 min; method and route dependent
Historical Status: Geref approved in 1997; later discontinued; FDA found withdrawal was not for safety or effectiveness reasons
COA: Independent third-party lab report — batch specific
Preparation: Lyophilized and QC released
Storage: −20°C sealed | 2–8°C after reconstitution
Shelf Life: 24 months unopened when stored as specified

BATCH TRACEABLE

Independent Analytical Record

Verify the Sermorelin Lot Before Study Use

Tested lots are accompanied by an independent third-party analytical report covering HPLC purity and mass-spectrometric identity. The report can be checked through the SaiyanMed Trust Center using the report identifier associated with the batch.

For laboratory traceability, confirm that the vial label, internal lot record, and third-party report refer to the same batch before opening the product.

📦 Storage & Handling

🧊 Storage

Keep unopened lyophilized vials sealed at −20°C, protected from moisture and direct light. After reconstitution, store at 2–8°C and apply the stability window defined by the laboratory protocol; SaiyanMed recommends use within 2–4 weeks unless a validated study establishes another interval. Avoid repeated freeze-thaw cycles. Do not use a solution that is cloudy, discolored, or visibly particulate.

💧 Reconstitution

Introduce 1–2 mL of an appropriate sterile laboratory diluent slowly against the vial wall. Avoid vigorous agitation; allow the powder to hydrate, then swirl gently until dissolved. The final solution should be clear and colorless. Prepare any working concentration according to a documented laboratory protocol.

🚚 Fulfillment & Transit Notice

Dispatch routing: Orders are assigned to the closest available fulfillment location. Eligible US orders are dispatched from US inventory; other destinations are generally served from the Asian logistics hub.

Transit conditions: Lyophilized material tolerates the ordinary ambient-temperature exposure associated with standard transport. Store at −20°C promptly after delivery rather than leaving the vial at room temperature.

International clearance: Customs review, document requests, duties, or temporary holds may occur with cross-border research-material shipments. Import compliance and local charges remain the consignee’s responsibility.

Tracking exceptions: For a shipment that remains stalled beyond the quoted delivery window, provide the order reference to support so the carrier status can be investigated and the applicable shipping policy applied.

Arrival inspection: Check the vial count, labels, and packaging immediately. Report damage or an incorrect item within the policy period and include clear photographs.


⚠

Laboratory Research Material

Sermorelin supplied on this page is intended only for controlled scientific work by appropriately qualified personnel.

Research Use Only

Not a Medicine or Consumer Product

This material is not supplied for self-administration, clinical treatment, diagnosis, disease prevention, performance enhancement, or any other personal-use purpose.

It is not intended for human consumption or veterinary use. Historical discussion of Geref is provided only to identify the molecule and its regulatory background; it does not describe or imply an approved use for the SaiyanMed research product.

✅ Buyer Confirmation

✓ You are qualified to purchase and handle laboratory research materials or are acting under appropriate institutional supervision.

✓ The product will be used only in lawful in vitro or in vivo research conducted under an approved protocol.

✓ You understand that this SaiyanMed product has not been reviewed or approved by the FDA for human or veterinary use.

✓ You accept responsibility for jurisdictional compliance, receipt, storage, documentation, use, and disposal.

Research variability and warranty: Material is supplied “as is” for research purposes. No warranty is made regarding biological outcome, fitness for a particular experiment, or reproducibility outside the stated analytical specifications. Study design, controls, interpretation, and conclusions remain the researcher’s responsibility.

🛡 General Safety & Handling

🚫 No Personal Use
Do not ingest, inject, apply, dispense, prescribe, or administer this material to any person or animal.

🥽 Laboratory PPE
Use suitable gloves, protective clothing, eye protection, and containment procedures for the planned work.

🌡 Controlled Storage
Record receipt and storage temperatures and limit exposure to heat, light, moisture, and repeated freeze-thaw cycles.

🗑 Approved Disposal
Dispose of unused material, solutions, and contaminated consumables under institutional chemical and biological waste procedures.

🧾 Lot Verification
Match the product label to the batch COA and review identity and purity results before incorporating the material into a study.

⚖ Local Compliance
Confirm that purchase, import, possession, experimental use, transfer, and disposal are permitted in the applicable jurisdiction.

💬 Frequently Asked Questions

What is Sermorelin?+

Sermorelin is the C-terminally amidated 1–29 fragment of human GHRH. It is a 29-amino-acid GHRH-receptor agonist used here as a laboratory reference material for receptor-signalling, peptide-stability, and GHRH-analog research.

How does Sermorelin differ from Mod GRF 1-29?+

Sermorelin retains the unmodified human GHRH(1-29) sequence. Mod GRF 1-29 contains substitutions at residues 2, 8, 15, and 27 that improve resistance to enzymatic degradation, so it generally persists longer in experimental systems.

Was Sermorelin previously an FDA-approved drug?+

Yes. Geref (sermorelin acetate) appears under FDA NDA 020443, with an original approval date of September 26, 1997. The listed products are discontinued, and the FDA later determined that they were not withdrawn for reasons of safety or effectiveness. This history does not apply pharmaceutical approval to the SaiyanMed research material.

How is batch quality documented?+

SaiyanMed releases each lot against HPLC purity and mass-spectrometric identity criteria. A batch-specific independent third-party report is provided for external verification.

How should Sermorelin be stored?+

Store unopened lyophilized vials at −20°C, sealed and protected from moisture and light. After reconstitution, keep at 2–8°C, avoid repeated freeze-thaw cycles, and follow the study’s validated stability window.

Is this product intended for human or veterinary use?+

No. This product is supplied strictly for controlled laboratory research. It is not a pharmaceutical product and must not be used for consumption, administration, diagnosis, treatment, prevention, performance enhancement, or personal experimentation.

📚 References

PubChem:
Sermorelin (CID 16132413) — compound identifiers, molecular formula, calculated molecular weight, and structure data.
View at PubChem ↗
Prakash A, Goa KL. (1999):
Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 12(2):139–157. PMID 18031173.
View at PubMed ↗
Frohman LA, et al. (1986):
Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest. 78(4):906–913. PMID 3093533.
View at NCBI ↗
Soule S, King JA, Millar RP. (1994):
Incorporation of D-Ala2 in growth hormone-releasing hormone-(1-29)-NH2 increases the half-life and decreases metabolic clearance in normal men. J Clin Endocrinol Metab. 79(4):1208–1211. PMID 7962295.
View at PubMed ↗
FDA Drugs@FDA:
GEREF (sermorelin acetate), NDA 020443 — approval history and discontinued marketing status.
View at FDA ↗
U.S. Federal Register (2013):
FDA determination that listed GEREF presentations were not withdrawn from sale for reasons of safety or effectiveness.
View Federal Register notice ↗

Additional information

Concentration & Vial

10mg x 10 vials, 5mg x 10 vials

Reviews

There are no reviews yet.

Be the first to review “Sermorelin”

Your email address will not be published. Required fields are marked *